Browsing: Merck

Sundry PhotographyThe FDA has accepted Merck’s (NYSE:MRK) supplemental New Drug Application with priority review for its drug Welireg, also known…

Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication Keytruda…

narvikkSummit Therapeutics (NASDAQ:SMMT), a drug developer challenging pharma giant Merck’s (NYSE:MRK) dominance in lung cancer, won a new buy recommendation…

JHVEPhoto/iStock Editorial via Getty Images Merck (NYSE:MRK) is ceasing development of two monoclonal antibody candidates it was eying as fixed-doses…